Amdocs Limited reported $5.00B of revenue over the trailing twelve months, +2.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.00B (to FY2024). Net income: $493M, trailing twelve months to FY2024. Free cash flow: $619M, trailing twelve months to FY2024. Operating margin: 13%, trailing twelve months to FY2024.

DOXAmdocs Limited

Technology

$58.85-28% 1Y

$58.85

$49.8752 weeks$84.19

DOX as reported

Amdocs Limited reported $5.00B of revenue over the trailing twelve months, +2.4% on the year before. 11 reported series are charted on this page, each one as filed.

$5.00B

Revenue, trailing twelve months · to FY2024 · +2.4% against the twelve months before

Net income: $493M
Net income · −8.8% year on year · trailing twelve months to FY2024
Free cash flow: $619M
Free cash flow · −11% year on year · trailing twelve months to FY2024
Operating margin: 13%
Operating margin · trailing twelve months to FY2024

Details›

Every series Ryufin has for DOX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.00B	+2.4%	FY2024
Net income	$493M	−8.8%	FY2024
EPS	$4.25	−5.3%	FY2024
Gross margin	35%	n/a	FY2024
Operating margin	13%	n/a	FY2024
Net margin	9.9%	n/a	FY2024
ROE	14%	n/a	FY2024
ROA	7.7%	n/a	FY2024
ROIC	14%	n/a	FY2024
Free cash flow	$619M	−11%	FY2024
P/E	13.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.